Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cell-mediated Immune Responses

Cell-mediated Immune Responses

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cytokine armored CAR T cells for cancer immunotherapy.

Immunology and cell biology·2026

Same author

CDK4/6 inhibition enhances CAR-T cell therapy in solid tumors.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Same author

Auto-inducible expression of chimeric antigen receptor T cells using the NR4A1 promoter.

Immunology and cell biology·2026

Same author

High efficiency CRISPR knock-in demonstrates that TCF1 is insufficient to reverse T cell exhaustion.

Nature communications·2026

Same author

Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8<sup>+</sup> T cells in lymph nodes.

Nature immunology·2026

Same author

Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

Same journal

Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.

Cancer cell·2026

Same journal

Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.

Cancer cell·2026

Same journal

Intratumoral B cells under stress.

Cancer cell·2026

Same journal

Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth.

Cancer cell·2026

Same journal

Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts.

Cancer cell·2026

Same journal

OpenIO: An open framework for AI-native immunotherapy.

Cancer cell·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 5, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

A metabolic pathway for improving adoptive cellular therapy.

Christina M Scheffler¹, Paul A Beavis¹, Phillip K Darcy²

¹Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville VIC 3010, Australia.

|December 13, 2024

Summary

This summary is machine-generated.

Exhausted T cells show reduced mannose metabolism, a novel finding. Targeting this pathway can improve anti-tumor efficacy by enhancing T cell persistence and memory.

More Related Videos

Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry

Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry

Published on: December 26, 2019

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Related Experiment Videos

Last Updated: Jun 5, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry

Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry

Published on: December 26, 2019

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Area of Science:

Immunology
Metabolic pathways
Cancer research

Background:

T cell exhaustion impairs anti-tumor immunity.
Metabolic reprogramming is crucial for T cell function.
Understanding T cell exhaustion mechanisms is vital for cancer therapy.

Purpose of the Study:

To identify novel metabolic features of exhausted T cells.
To investigate the role of mannose metabolism in T cell exhaustion.
To explore therapeutic strategies targeting T cell metabolism for improved anti-cancer effects.

Main Methods:

Single-cell metabolic analysis.
Characterization of T cell exhaustion markers.
In vivo studies of adoptively transferred T cells.

Main Results:

Reduced mannose metabolism identified as a key feature of exhausted T cells.
Targeting mannose metabolism enhanced memory and persistence of adoptively transferred T cells.
Improved anti-tumor efficacy observed when mannose metabolism was modulated.

Conclusions:

Mannose metabolism is a critical, previously unrecognized factor in T cell exhaustion.
Modulating mannose metabolism represents a promising strategy to enhance adoptive T cell therapy for cancer.
This finding opens new avenues for improving cancer immunotherapy.